Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 123 Next »
Viewing Page 1 of 3 | Showing Results 1 - 5 of 12

John Wayne Cancer Institute Biospecimen Repository

Jose Esteban, M.D.
  • Disney Family Cancer Center (DFCC)
  • Providence Los Angeles Research Center
  • Providence St. Joseph Medical Center (PSJMC)

EA5142: Adjuvant Nivolumab in Resected Lung Cancers (ANVIL) A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers

This randomized phase III trial studies how well nivolumab after surgery and chemotherapy work in treating patients with stage IB-IIIA non-small...

Timothy Byun, M.D.
  • SJH Southern California
  • St. Joseph Hospital of Orange

NRG-LU002 Maintenance Systemic Therapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial

This randomized phase II/III trial studies how well giving maintenance chemotherapy with or without stereotactic body radiation therapy works in...

Robert Ash, M.D.
  • SJH Southern California
  • St. Joseph Hospital of Orange

Phase 2, Parallel-Arm Study of MGCD265 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Activating Genetic Alterations in Mesenchymal-Epithelial Transition Factor

Inclusion Criteria: •Diagnosis of non-small cell lung cancer •Metastatic or locally advanced disease •Prior platinum chemotherapy or...

Raul Mena, M.D.
  • Disney Family Cancer Center (DFCC)
  • Providence Los Angeles Research Center

A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy in the Treatment of Patients of Patients with HER2+ Metastatic Breast Cancer Who Have Received Prior Anti-HER2 Therapies and Require Systemic Treatment

Inclusion Criteria: Histologically-proven metastatic or locally-advanced relapsed/refractory HER2+ breast cancer based on the most recently...

Raul Mena, M.D.
  • Disney Family Cancer Center (DFCC)
  • Providence Los Angeles Research Center
« Previous 123 Next »
Viewing Page 1 of 3 | Showing Results 1 - 5 of 12